Details for New Drug Application (NDA): 019009
✉ Email this page to a colleague
The generic ingredient in MAXAIR is pirbuterol acetate. There are three drug master file entries for this compound. Additional details are available on the pirbuterol acetate profile page.
Summary for 019009
Tradename: | MAXAIR |
Applicant: | Bausch |
Ingredient: | pirbuterol acetate |
Patents: | 0 |
Profile for product number 001
Active Rx/OTC/Discontinued: | DISCN | Dosage: | AEROSOL, METERED;INHALATION | Strength | EQ 0.2MG BASE/INH | ||||
Approval Date: | Dec 30, 1986 | TE: | RLD: | No |
Expired US Patents for NDA 019009
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
---|---|---|---|---|---|---|---|
Bausch | MAXAIR | pirbuterol acetate | AEROSOL, METERED;INHALATION | 019009-001 | Dec 30, 1986 | ⤷ Sign Up | ⤷ Sign Up |
Bausch | MAXAIR | pirbuterol acetate | AEROSOL, METERED;INHALATION | 019009-001 | Dec 30, 1986 | ⤷ Sign Up | ⤷ Sign Up |
Bausch | MAXAIR | pirbuterol acetate | AEROSOL, METERED;INHALATION | 019009-001 | Dec 30, 1986 | ⤷ Sign Up | ⤷ Sign Up |
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >Patent No. | >Patent Expiration |
Complete Access Available with Subscription